Sevelamer hydrochloride

Drug Profile

Sevelamer hydrochloride

Alternative Names: Tasermity

Latest Information Update: 27 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Genzyme Europe
  • Class Polyamines
  • Mechanism of Action Chelating agents; Phosphate binding protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Hyperphosphataemia

Most Recent Events

  • 26 Feb 2015 Registered for Hyperphosphataemia (In adults) in European Union (PO)
  • 18 Dec 2014 Preregistration for Hyperphosphataemia (In adults) in European Union (PO)
  • 30 May 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top